Trials / Completed
CompletedNCT02040844
Phase III Cat-PAD Follow-on Study
An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 430 (actual)
- Sponsor
- Circassia Limited · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the continued effectiveness and safety of Cat-PAD in cat allergic subjects for up to five years after the start of administration of treatment. The study is an optional follow-up study to a phase III double-blind, placebo controlled, Cat-PAD study; no further investigational product is administered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762] | |
| DRUG | Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762] | |
| DRUG | Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762] |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2014-01-20
- Last updated
- 2018-06-15
- Results posted
- 2018-05-14
Source: ClinicalTrials.gov record NCT02040844. Inclusion in this directory is not an endorsement.